Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,087,210
-
Share change
-
-218,993
-
Total reported value
-
$5,773,000
-
Price per share
-
$1.87
-
Number of holders
-
20
-
Value change
-
-$528,999
-
Number of buys
-
8
-
Number of sells
-
12
Institutional Holders of ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) as of Q1 2022
As of 31 Mar 2022,
ENTASIS THERAPEUTICS HLDGS I - COM (ETTX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,087,210 shares.
The largest 10 holders included
TPG GP A, LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BRIDGEWAY CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, GABELLI FUNDS LLC, Janney Montgomery Scott LLC, and Knott David M Jr.
This page lists
20
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.